Writing or reviewing a manuscript? Watch out for these ten common statistical mistakes elifesciences.org/articles/48175…

Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence doi.org/10.7554/eLife.…

Evaluation of nine commercial SARS-CoV-2 immunoassays medrxiv.org/content/10.110…

Today we're sharing an analysis of the genetics behind two important COVID-19 genes: ACE2 and TMPRSS2. A thread on what we have found 1/9 medrxiv.org/content/10.110… Lifelines Serena Sanna

Viral loads by PCR as seen in our laboratories. No significant difference between children and adults. Age categories: Kindergarten (KG), Grade school (GS), Highschool (HS), etc. with age ranges and (counts). bit.ly/SARS-2-load

Numerous research teams are using a variety of approaches to develop #COVID19 vaccines. @nature explores the technologies in this graphical guide 📝👇 nature.com/articles/d4158…

The #SARS_CoV2 pandemic could have been prevented - my opinion, at virology blog. Please take the time to read it and be outraged. bit.ly/2xnKjxh

Analysis of antibody responses to 15 #SARSCoV2 antigens using Luciferase Immunoprecipitation System shows that antibodies against N, ORF3b, and ORF8 come up at early time points of illness. N is the immunodominant antigen. Beyond the Spike. The University of Hong Kong medrxiv.org/content/10.110…

Germany have handled the Covid-19 outbreak incredibly well, but even they have seen infections rise above R=1 when easing the lockdown. Please RT if you’re happy for our lockdown to stay in place for as long as it takes. bbc.com/news/world-eur…

Emergence of SARS-CoV-2 through recombination and strong purifying selection advances.sciencemag.org/content/early/…

We’ve just had a paper published and I would like to tell you a story about people in science being nice to each other – a thread cell.com/cell/fulltext/…

Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 biorxiv.org/content/10.110…

Grant writing advice. Many people get too detailed and assume background knowledge of the reviewer too quickly. Your grant early on needs to answer (in my view) these questions:

Stoked to report in @nature the discovery of prokaryotic viperins, which naturally produce diverse anti-viral molecules ! After providing us with antibiotics, bacteria might become sources of novel anti-viral drugs. (1/9) nature.com/articles/s4158…

Very excited to share some of our lab’s work on SARS-CoV-2. This was a huge team effort – so many people in lab worked hard on this. This is still a preprint. We’ve found one possible reason why SARS-CoV-2 went pandemic and SARS-CoV didn’t. biorxiv.org/content/10.110… Thread... 1/n

Manuscript on the SARS-CoV-2 spike mutations arising in Danish mink, their spread to humans and neutralization data bit.ly/3eXXtT8 from State Serum Institute in Denmark from Anders Fomsgaard I would like them to measure infectious virus not just antigen

Further analysis of subgroups will follow but for patients admitted with COVID no difference in 28 day mortality for convalescent plasma 2 units with neutab > 1:100. Huge thanks to RECOVERY team Peter Horby Martin Landray and Dr Lise Estcourt and Clinical Trials Unit and 100s at NHS Blood+Transplant

Today, World Health Organization (WHO) announces new, easy-to-say labels for #SARSCoV2 Variants of Concern (VOCs) & Interest (VOIs) They will not replace existing scientific names, but are aimed to help in public discussion of VOI/VOC Read more here (will be live soon): who.int/activities/tra… #COVID19

Two virology postdoc positions available in our lab, developing nanobodies and small molecule antivirals. Closing date end of January so please apply ASAP. my.corehr.com/pls/uoxrecruit… Any questions? Please email Miles: [email protected]